Naproxen Sodium Diphenhydramine HCL NDC 79903-204

NDC codes

FDA NDC Directory

Product NDC (as listed)79903-204Labeler and product segments. Claims need a package NDC.

Product NDC at billing width79903-0204Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
79903-204-20	79903020420	20 TABLET in 1 BOTTLE (79903-204-20)Marketed from Dec 14, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naproxen Sodium Diphenhydramine HCL
Generic name (nonproprietary): naproxen sodium diphenhydramine hcl
Active ingredients: Diphenhydramine hydrochloride — 25 mg/1Naproxen sodium — 220 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Walmart
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213663
Marketing start: Dec 14, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 79903-204_464fe3e4-2030-838c-e063-6294a90acc3aSPL ID 464fe3e4-2030-838c-e063-6294a90acc3aSPL set ID fe810c0e-ab42-5a8a-e053-6394a90affe4RxCUI 1550957UNII TC2D6JAD40, 9TN87S3A3C
Pharmacologic class: Histamine-1 Receptor Antagonist; Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N479903020420 followed by a unit qualifier and the quantity

Package 79903-0204-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 19, 2025.

Indications (excerpt from the label)

Uses 􀂄 for relief of occasional sleeplessness when associated with minor aches and pains 􀂄 helps you fall asleep and stay asleep

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213663

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213663
Product	Strength	Form · route	Labeler	Product NDC
Naproxen Sodium Diphenhydramine HCl	Naproxen sodium 220 mg/1; Diphenhydramine hydrochloride 25 mg/1	Tablet, Film coatedOral	CVS PHARMACY, INC	69842-328
Naproxen Sodium and Diphenhydramine HCL	Diphenhydramine hydrochloride 25 mg/1; Naproxen sodium 220 mg/1	TabletOral	TARGET CORPORATION	11673-819
Naproxen Sodium and Diphenhydramine HCl	Naproxen sodium 220 mg/1; Diphenhydramine hydrochloride 25 mg/1	Tablet, Film coatedOral	Granules India Ltd	62207-814
Naproxen Sodium Diphenhydramine Hydrochloride	Naproxen sodium 220 mg/1; Diphenhydramine hydrochloride 25 mg/1	TabletOral	SAFEWAY	21130-814